MX2010010244A - Forma cristalina de n-[[4-fluoro-2-(5-metil-1h-1,2,4-triazol-1-il) fenil]metil]-4,6,7,9-tetrahidro-3-hidroxi-9,9-dimetil-4-oxo-pirim ido[2,1-c][1,4]oxazin-2-carboxamida, sal sodio monohidratada. - Google Patents
Forma cristalina de n-[[4-fluoro-2-(5-metil-1h-1,2,4-triazol-1-il) fenil]metil]-4,6,7,9-tetrahidro-3-hidroxi-9,9-dimetil-4-oxo-pirim ido[2,1-c][1,4]oxazin-2-carboxamida, sal sodio monohidratada.Info
- Publication number
- MX2010010244A MX2010010244A MX2010010244A MX2010010244A MX2010010244A MX 2010010244 A MX2010010244 A MX 2010010244A MX 2010010244 A MX2010010244 A MX 2010010244A MX 2010010244 A MX2010010244 A MX 2010010244A MX 2010010244 A MX2010010244 A MX 2010010244A
- Authority
- MX
- Mexico
- Prior art keywords
- methyl
- oxazine
- triazol
- carboxamide
- tetrahydro
- Prior art date
Links
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 title abstract 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 title abstract 4
- NASFKTWZWDYFER-UHFFFAOYSA-N sodium;hydrate Chemical compound O.[Na] NASFKTWZWDYFER-UHFFFAOYSA-N 0.000 title abstract 4
- 208000030507 AIDS Diseases 0.000 abstract 1
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 208000037357 HIV infectious disease Diseases 0.000 abstract 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3998908P | 2008-03-27 | 2008-03-27 | |
| PCT/US2009/038362 WO2009120841A1 (en) | 2008-03-27 | 2009-03-26 | Crystalline form of n-[[4-fluoro-2-(5-methyl-1h-1,2,4-triazol-1-yl)phenyl]methyl]-4,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide, sodium salt monohydrate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010010244A true MX2010010244A (es) | 2010-10-05 |
Family
ID=41008867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010010244A MX2010010244A (es) | 2008-03-27 | 2009-03-26 | Forma cristalina de n-[[4-fluoro-2-(5-metil-1h-1,2,4-triazol-1-il) fenil]metil]-4,6,7,9-tetrahidro-3-hidroxi-9,9-dimetil-4-oxo-pirim ido[2,1-c][1,4]oxazin-2-carboxamida, sal sodio monohidratada. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7968541B2 (enExample) |
| EP (1) | EP2280980B1 (enExample) |
| JP (1) | JP2011515491A (enExample) |
| KR (1) | KR20100138959A (enExample) |
| CN (1) | CN102046637B (enExample) |
| AU (1) | AU2009228254A1 (enExample) |
| MX (1) | MX2010010244A (enExample) |
| WO (1) | WO2009120841A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106478661A (zh) * | 2015-08-25 | 2017-03-08 | 华北制药集团新药研究开发有限责任公司 | 苯并恶唑并恶嗪酮类化合物wa1-089的晶型e及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK9742002A3 (en) * | 2000-01-07 | 2003-02-04 | Transform Pharmaceuticals Inc | High-throughput formation, identification, and analysis of diverse solid-forms |
| US7157447B2 (en) * | 2004-05-28 | 2007-01-02 | Bristol-Myers Squibb Company | Bicyclic heterocycles as HIV integrase inhibitors |
| US7176196B2 (en) * | 2004-05-28 | 2007-02-13 | Bristol-Myers Squibb Company | Bicyclic heterocycles as HIV integrase inhibitors |
| WO2007064316A1 (en) * | 2005-11-30 | 2007-06-07 | Bristol-Myers Squibb Company | Bicyclic heterocycles as hiv integrase inhibitors |
| WO2007064502A1 (en) * | 2005-12-01 | 2007-06-07 | Bristol-Myers Squibb Company | Forms of n-[(4-fluorophenyl)methyl]-4,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide |
| US7897593B2 (en) * | 2006-05-30 | 2011-03-01 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
-
2009
- 2009-03-26 AU AU2009228254A patent/AU2009228254A1/en not_active Abandoned
- 2009-03-26 KR KR1020107021250A patent/KR20100138959A/ko not_active Withdrawn
- 2009-03-26 EP EP09725033.6A patent/EP2280980B1/en not_active Not-in-force
- 2009-03-26 WO PCT/US2009/038362 patent/WO2009120841A1/en not_active Ceased
- 2009-03-26 CN CN2009801193916A patent/CN102046637B/zh not_active Expired - Fee Related
- 2009-03-26 JP JP2011502043A patent/JP2011515491A/ja active Pending
- 2009-03-26 MX MX2010010244A patent/MX2010010244A/es active IP Right Grant
- 2009-03-26 US US12/411,475 patent/US7968541B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009120841A1 (en) | 2009-10-01 |
| EP2280980A1 (en) | 2011-02-09 |
| JP2011515491A (ja) | 2011-05-19 |
| KR20100138959A (ko) | 2010-12-31 |
| AU2009228254A1 (en) | 2009-10-01 |
| US7968541B2 (en) | 2011-06-28 |
| US20090253692A1 (en) | 2009-10-08 |
| CN102046637B (zh) | 2013-10-02 |
| CN102046637A (zh) | 2011-05-04 |
| EP2280980B1 (en) | 2016-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY153093A (en) | Crystalline forms of a 2-thiazolyl-4-quinolinyl-oxy derivative, a potent hcv inhibitor | |
| TN2011000400A1 (en) | Inhibitors of beta-secretase | |
| WO2007103550A3 (en) | Substituted aminothiazole derivatives with anti-hcv activity | |
| IN2012DN01325A (enExample) | ||
| MX2009008338A (es) | Compuestos de piridopirimidinona de utilidad en el tratamiento de enfermedades o condiciones patologicas mediadas por los canales de sodio. | |
| TW200508244A (en) | Process to branched ribonucleosides | |
| MX2009009920A (es) | Inhibidores no nucleosidos de transcriptasa inversa. | |
| WO2010021680A3 (en) | Inhibitors of beta-secretase | |
| WO2009026176A3 (en) | Antiinfective flavononol compounds and methods of use thereof | |
| MY171577A (en) | 2',4'-difluoro-2'-methyl substituted nucleoside derivatives as inhibitors of hcv rna replication | |
| MX2010008460A (es) | Derivado de tiazol y su uso como inhibidor de proteina-1 de adhesion vascular. | |
| TW201000473A (en) | Benzene or thiophene derivative and use thereof as VAP-1 inhibitor | |
| GEP20156368B (en) | Non-nucleoside reverse transcriptase inhibitors | |
| MX2010008921A (es) | Derivados de oxazolidinona. | |
| NZ594403A (en) | Amorphous salt of a macrocyclic inhibitor of hcv | |
| MX2010007584A (es) | Inhibidores de proteina cinasa y uso de los mismos. | |
| MX350746B (es) | Derivados de ciclosporina novedosos para el tratamiento y la prevención de una infección viral. | |
| WO2009018065A3 (en) | Novel glucokinase activators and methods of using same | |
| MX2008010884A (es) | Acidos 4-fenil-tiazol-5-carboxilicos y amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1. | |
| GEP20166481B (en) | (crystalline forms of hydrochloride salt of (4a-r, 9a-s)-1-(1h-benzoimidazole-5-carbonyl)-2, 3, 4, 4a, 9, 9a-hexa- hydro-1h-indeno [2, 1-b] pyridine-6-carbonitrile and their use as hsd 1 inhibitors | |
| IN2012DN02502A (enExample) | ||
| NZ596820A (en) | Trans-4-[[(5s)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl] (2-methyl-2h-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1h-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid | |
| TW200700069A (en) | Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives | |
| MX2008016358A (es) | Derivados de tiazolil-urea como inhibidores de cinasa de fosfatidil-inositol-3. | |
| TW200942529A (en) | Pyrrolidinyl derivatives and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |